V2703
antibody from NSJ Bioreagents
Targeting: MFGE8
BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [4]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2703 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- MFGE8 Antibody
- Antibody type
- Monoclonal
- Antigen
- A human milk fat globule membrane preparation was used as the immunogen for the MFGE8 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- MFG-06
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the MFGE8 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells.
Malignant transformation of rat kidney induced by environmental substances and estrogen.
Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Yamazaki M, Maruyama S, Abé T, Essa A, Babkair H, Cheng J, Saku T
Laboratory investigation; a journal of technical methods and pathology 2014 Nov;94(11):1260-72
Laboratory investigation; a journal of technical methods and pathology 2014 Nov;94(11):1260-72
Malignant transformation of rat kidney induced by environmental substances and estrogen.
Alfaro-Lira S, Pizarro-Ortiz M, Calaf GM
International journal of environmental research and public health 2012 May;9(5):1630-48
International journal of environmental research and public health 2012 May;9(5):1630-48
Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS
Molecular endocrinology (Baltimore, Md.) 2010 Feb;24(2):359-69
Molecular endocrinology (Baltimore, Md.) 2010 Feb;24(2):359-69
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Western blot testing of MCF7 cell lysate with MFGE8 antibody (clone MFG-06).
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human breast carcinoma stained with MFGE8 antibody (MFG-06)
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC: FFPE human pancreas tested with MFGE8 antibody (MFG-06)
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC: FFPE human lung carcinoma tested with MFGE8 antibody (MFG-06)
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC: FFPE human renal cell carcinoma tested with MFGE8 antibody (MFG-06)
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- SDS-PAGE Analysis of Purified, BSA-Free MFGE8 Antibody (clone MFG-06). Confirmation of Integrity and Purity of the Antibody.